Skip to main content

Tiziana Life Sciences Ltd

TLSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723069

In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Tiziana Life Sciences Ltd changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of TLSA: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders32130−1
Shares3.00M10.0K4.56M+1.57M (+52.6%)
Value$3.25M$10.8K$4.04M+$800.4K (+24.7%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Tiziana Life Sciences Ltd at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to TLSA in Q2 2025
InstitutionSharesValue% of portfolio
Citadel Advisors LLC198,990$314.4K0.00%
Simplex Trading, LLC67,251$106.0K0.00%
Marshall Wace, LLP24,369$38.5K0.00%
Caitlin John, LLC10,000$15.8K0.01%
Raymond James Financial Inc500$7900.00%

Sold out (6)

Institutions that held Tiziana Life Sciences Ltd at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of TLSA in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Omers Administration Corp144,900$156.5K
Cubist Systematic Strategies, LLC22,825$24.7K
Cantor Fitzgerald, L. P.11,491$12.4K
Novem Group10,000$10.8K
BNP Paribas Arbitrage, SA1,933$2.09K
JPMorgan Chase & Co100$108

Not filed for Q2 2025 yet (1)

Institutions that held Tiziana Life Sciences Ltd at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TLSA in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Credit Agricole S A10,000$10.8K